Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes

被引:113
作者
Rasmusson, Ida
Uhlin, Michael
Le Blanc, Katarina
Levitsky, Victor
机构
[1] Karolinska Univ Hosp, Div Clin Immunol, S-14186 Stockholm, Sweden
[2] Karolinska Inst, Div Clin Immunol, Stockholm, Sweden
[3] Karolinska Inst, Tumor Biol Ctr, Div Microbiol, Stockholm, Sweden
[4] Karolinska Inst, Hematol Ctr, Div Clin Immunol, Stockholm, Sweden
关键词
marrow stromal cells; effector CD8 T cells; activation; EBV; alloantigen;
D O I
10.1189/jlb.0307140
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mesenchymal stem cells (MSCs), isolated from adult human bone marrow, have immunomodulatory properties. The functional outcomes of MSCs-CTL interactions remain poorly characterized. In this study, we demonstrate that MSCs remain resistant to CTL lysis, even after pulsing with the specific synthetic peptide at high concentrations, in spite of surface expression of the relevant MHC class I allele. MSCs were also much less sensitive to lysis by an allo-specific CTL clone as compared with HLA-matched lymphoblastoid cell lines. MSCs induced CD25 up-regulation, albeit at relatively low levels, and were unable to induce CD3 or CD8 down-regulation at the surface of CTLs. MSCs also failed to induce IFN-gamma and TNF-alpha production by the CTLs. Furthermore, peptide-pulsed MSCs were inefficient in stimulating tyrosine phosphorylation in specific CTLs. Our results demonstrate that MSCs induce only an abortive activation program in fully differentiated, effector CTLs, which does not involve activation of major CTL effector functions. These data may have important implications for the development of therapeutic strategies based on administration of in vitro-expanded MSCs.
引用
收藏
页码:887 / 893
页数:7
相关论文
共 48 条
[1]   Human mesenchymal stem cells modulate allogeneic immune cell responses [J].
Aggarwal, S ;
Pittenger, MF .
BLOOD, 2005, 105 (04) :1815-1822
[2]  
Angoulvant D, 2004, BIORHEOLOGY, V41, P469
[3]   Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].
Bartholomew, A ;
Sturgeon, C ;
Siatskas, M ;
Ferrer, K ;
McIntosh, K ;
Patil, S ;
Hardy, W ;
Devine, S ;
Ucker, D ;
Deans, R ;
Moseley, A ;
Hoffman, R .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48
[4]   Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness [J].
Beyth, S ;
Borovsky, Z ;
Mevorach, D ;
Liebergall, M ;
Gazit, Z ;
Aslan, H ;
Galun, E ;
Rachmilewitz, J .
BLOOD, 2005, 105 (05) :2214-2219
[5]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[6]  
Cabestré FA, 1999, J REPROD IMMUNOL, V43, P183
[7]   Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation [J].
Chung, NG ;
Jeong, DC ;
Park, SJ ;
Choi, BO ;
Cho, B ;
Kim, HK ;
Chun, CS ;
Won, JH ;
Han, CW .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 80 (04) :370-376
[8]   T-CELL RESPONSES AND VIRUS EVOLUTION - LOSS OF HLA A11-RESTRICTED CTL EPITOPES IN EPSTEIN-BARR-VIRUS ISOLATES FROM HIGHLY A11-POSITIVE POPULATIONS BY SELECTIVE MUTATION OF ANCHOR RESIDUES [J].
DECAMPOSLIMA, PO ;
LEVITSKY, V ;
BROOKS, J ;
LEE, SP ;
HU, LF ;
DICKINSON, AB ;
MASUCCI, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (04) :1297-1305
[9]   Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates [J].
Devine, SM ;
Cobbs, C ;
Jennings, M ;
Bartholomew, A ;
Hoffman, R .
BLOOD, 2003, 101 (08) :2999-3001
[10]   Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli [J].
Di Nicola, M ;
Carlo-Stella, C ;
Magni, M ;
Milanesi, M ;
Longoni, PD ;
Matteucci, P ;
Grisanti, S ;
Gianni, AM .
BLOOD, 2002, 99 (10) :3838-3843